Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

Semaglutide was approved in 2017. By cutting edge, I suppose I mean covered by patent. Luckily for Canada, Novo Nordisk forgot to pay their for its renewal.

I was just pointing to an example of why healthcare reform is politically difficult. One relevant to the ACA was ending discrimination based on preexisting conditions, which caused a majority of people's premiums to go up to subsidize those who are chronically ill. Morally, most people agree it's the right thing to do, but it was politically disastrous since one person gets one vote.



Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: